Christopher Gaertner - DHC Acquisition CFO CoCEO
| DHCAUDelisted Stock | USD 10.25 0.00 0.00% |
Insider
Christopher Gaertner is CFO CoCEO of DHC Acquisition Corp
| Age | 61 |
| Phone | 310 228 2894 |
| Web | https://www.dhcacquisition.partners |
DHC Acquisition Management Efficiency
The company has return on total asset (ROA) of (0.0114) % which means that it has lost $0.0114 on every $100 spent on assets. This is way below average. DHC Acquisition's management efficiency ratios could be used to measure how well DHC Acquisition manages its routine affairs as well as how well it operates its assets and liabilities.DHC Acquisition Corp has accumulated 123.78 K in total debt with debt to equity ratio (D/E) of 0.02, which may suggest the company is not taking enough advantage from borrowing. DHC Acquisition Corp has a current ratio of 0.27, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about DHC Acquisition's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Bobak MD | Tarsus Pharmaceuticals | N/A | |
| CPA MST | Ardelyx | 50 | |
| Marcus Dijk | Mink Therapeutics | 62 | |
| Tia Bush | Centessa Pharmaceuticals PLC | 53 | |
| Karen Harrigan | Ardelyx | N/A | |
| Saurabh MD | Centessa Pharmaceuticals PLC | 48 | |
| MBA MD | Centessa Pharmaceuticals PLC | 51 | |
| Michael Ackermann | Tarsus Pharmaceuticals | 42 | |
| Jrg Breitkopf | Sellas Life Sciences | N/A | |
| ScD MD | Sellas Life Sciences | 48 | |
| Robert Barrow | Mind Medicine | 35 | |
| MD MBA | Mind Medicine | N/A | |
| John CPA | Sellas Life Sciences | 39 | |
| David Nakasone | Tarsus Pharmaceuticals | N/A | |
| Scott MD | Mind Medicine | 67 | |
| Susan Rodriguez | Ardelyx | 60 | |
| MD MSc | Centessa Pharmaceuticals PLC | 64 | |
| Dianne MSW | Tarsus Pharmaceuticals | 47 | |
| Joshua MBA | Centessa Pharmaceuticals PLC | 50 | |
| Wong JD | Mind Medicine | 54 | |
| Patrick MBA | Mink Therapeutics | N/A | |
Management Performance
| Return On Asset | -0.0114 |
DHC Acquisition Corp Leadership Team
Elected by the shareholders, the DHC Acquisition's board of directors comprises two types of representatives: DHC Acquisition inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DHC. The board's role is to monitor DHC Acquisition's management team and ensure that shareholders' interests are well served. DHC Acquisition's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DHC Acquisition's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Gaertner, CFO CoCEO | ||
| Thomas Morgan, CoChief Officer |
DHC Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DHC Acquisition a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.0114 | |||
| Current Valuation | 102.92 M | |||
| Price To Earning | 41.50 X | |||
| EBITDA | (13.53 M) | |||
| Net Income | 3.5 M | |||
| Cash And Equivalents | 405.64 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 123.78 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 0.28 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in DHC Stock
If you are still planning to invest in DHC Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DHC Acquisition's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |